General Information
edit

Website	antisense-pharma.com
Category	BioTech
Employees
Founded	1998
Description	German BioPharma Company

Offices
edit

Headquarters

Josef-Engert-Str. 9
Regensburg, 93053, DEU

Funding
edit

TOTAL	$39.9M
FUNDING TOTAL	$39.9M
Series E, 4/10 MIG AG Global Asset Fund	$17.5M
Venture Round, 7/11 MIG Funds	€8M
Series F, 1/12 MIG Fonds Global Asset Fund	$11M

Tags
edit

antisense, antisense-gene-splicing, german-biopharma

Antisense Pharma
edit

Anitsense Pharma a clinical-stage biopharmaceutical company focused on antisense gene silencing for pancreatic cancer, malignant melanoma and colorectal cancer

Recent Milestones
edit

Antisense Pharma received $11M in Series F funding. (1/26/12)

Posted 1/26/12 at 8:21pm via onbiovc.com
Antisense Pharma received $11.4M (€8M) in Venture Round funding. (7/7/11)

Posted 7/7/11 at 6:51pm via finsmes.com
Antisense Pharma received $17.5M in Series E funding. (4/5/10)

Posted 4/5/10 at 10:58pm via onbiovc.com